ePRO Resources
-
The Building Blocks Of DCT: How To Create A Seamless Experience Across eConsent, eCOA, And More
3/29/2022
With more than 76% of sponsors seeking to implement decentralized solutions this year, there’s never been more attention given to decentralized trials. Discover why decentralized trials must take a unified approach, one that alleviates burdens for patients and sites in order to drive cost savings and realize efficiencies.
-
How eCOA Improves Data Quality In Clinical Trials
11/20/2024
eCOA solutions enhance data quality in clinical trials by preventing common issues in paper-based COA data, such as missing, ambiguous, or conflicting entries, and ensuring reliable data collection.
-
From Paper To ePRO: Providing Flexibility And Efficiency
3/12/2024
Explore the transformative impact of flexible ePRO technology on clinical trials, elucidating how it enhances patient-centricity and operational efficiency for sponsors.
-
Rethinking Today's ePRO Delivery For Tomorrow's Clinical Trials
6/24/2024
Willie Muehlhausen, Co-CEO and Founder of Safira Clinical Research, and Tim Davis, VP of Strategy at MyVeeva for Patients, discuss how ePRO delivery needs to change to better serve modern trials.
-
eCOA Predictions For 2022
5/2/2022
Dive into the prediction that the rapid adoption of eCOAs will continue to grow in 2022, as sponsors acknowledge how useful these tools have become in decentralized clinical trial (DCT) settings.
-
Enhance Data Collection And Ensure Seamless Platform Integration
3/3/2025
Discover how to enable patient- and site-centric data collection, enhance participant engagement, reduce burden, and deliver valuable real-world insights on treatment effectiveness and quality of life.
-
Revolutionizing Pediatric Clinical Trials With ePRO And eConsent
10/16/2024
Digital tools like ePRO and eConsent are essential in addressing pediatric trial challenges such as the diverse participant ages and family involvement, which impact retention and data quality.
-
Transforming Oncology Trials With Next-Gen eCOA
6/9/2025
With the FDA stating last fall that the “patient’s voice” is key to understanding real-world-impacts, eCOAs and ePROs are becoming quintessential tools for cancer trials.
-
Why ePROs In Oncology Are Perfect For Capturing The Patient's Voice
5/15/2025
Recently released FDA guidance showcases why electronic patient-reported outcomes (ePROs) are ideal for capturing the “voice” of the patient. See how ePRO eases oncology trials.
-
Simple, Cost-Effective Ways To Engage Patients Using eCOA And IRT
9/7/2022
Today, patients are exposed to sophisticated technology, which presents a huge opportunity to elevate engagement. Consider some common elements when initiating engagement during clinical development.